Status:
UNKNOWN
Comparison Levobupivacaine and Ropivacaine for TAP-block After Caesarean Section
Lead Sponsor:
Alexandr Ronenson
Conditions:
Pain, Postoperative
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Randomized, double-blind, controlled trial: a comparison of Levobupivacaine and Ropivacaine for postoperative analgesia using TAP-block Objectives: 1. VAS score during the first 12 hours 2. Determin...
Detailed Description
For TAP-block was used Hirokain® (Levobupivacaine) . Injectable solution 7.5 mg / ml; ampoule polypropylene 10 ml, a pack of cardboard 10; No. ЛП-003106, 2015-07-21 to 2020-07-21 from EbbVi Ltd. (Russ...
Eligibility Criteria
Inclusion
- Cesarean section pfannenstiel incision under spinal anesthesia
- Spinal anesthesia with Bupivacaine heavy 0,5%
- Without any adjuvants
Exclusion
- Any other anesthesia exept spinal
- Any other surgical incision
Key Trial Info
Start Date :
September 25 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03302689
Start Date
September 25 2017
End Date
January 1 2018
Last Update
October 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tver Regional Perinatal Center
Tver', Russia